ReWalk Robotics Ltd. (LFWD) Stock

ReWalk Robotics Ltd., a prominent medical device company, specializes in designing, developing, and commercializing advanced technologies that enhance mobility and improve quality of life for individuals with physical and neurological conditions worldwide. The company's innovative product lineup includes the ReWalk personal exoskeleton and rehabilitation exoskeleton devices, which enable individuals with spinal cord injuries to walk independently. Additionally, ReWalk offers the ReStore soft exo-suit designed for lower limb rehabilitation post-stroke, along with the AlterG Anti-Gravity System for physical and neurological rehabilitation and athletic training. Their MyoCycle devices and ReBoot personal soft exo-suit further support rehabilitation efforts for individuals recovering from stroke, enhancing their ability to navigate home and community environments.

ReWalk Robotics markets and distributes its products directly to healthcare institutions and individual users, as well as through strategic partnerships with third-party distributors. This multi-channel approach ensures broad accessibility to their innovative mobility solutions across diverse global markets.

Founded in 2001 and headquartered in Yokneam Illit, Israel, ReWalk Robotics Ltd. was originally established as Argo Medical Technologies Ltd. The company has since evolved to become a leader in the field of robotic exoskeleton technology, comitted to advancing rehabilitation outcomes and empowering individuals with mobility impairments to regain independence and improve their daily lives.